Biofire got FDA approval fast, but it hasn't done much good

New Post Public Reply Private Reply Replies (0) Message Board
shabby45 kraztkat #727
Biofire got FDA approval fast, but it hasn't done much good so far:

http://7online.com/health/new-test-for-diagno...ed/369875/

NEW YORK (WABC) -- When it comes to Ebola, diagnosing patients early and finding their contact immediately is critical.

But when a five-year old boy who recently came back from West Africa started to have a fever Monday morning, New York City used a test that can take up to 12 hours.

Monday night, it came back negative.

But they had another option. A new test could have given them the answer in an hour.

So why didn't the city use it?

The Food and Drug Administration has approved the use of a one-hour Ebola test that can be done right in the hospital.

But at least for now, it won't be used here in New York, not until the city and state are convinced of its accuracy.

The medical device, the size of a small printer, can accurately test blood or urine samples for Ebola in one hour:

"Time can make a difference, every hour matters," said Kirk Ririe, CEO of BioFire Defense.

The head of the Midwest company that makes the one-hour Ebola testing machine says when the FDA gave the device an Emergency Approval for use by hospitals last Saturday, he was on his way to Bellevue to assist them in its use.

"We flew to New York, received clearance, authorization while we were in the air," said Ririe.

But we've learned that city and state health officials stepped in and stopped the use of the one-hour testing device despite F-D-A's emergency approval. That meant when the 5 year old boy back from Guinea was admitted to Bellevue's Ebola Ward, the next day, it took ten hours from the time he spiked a fever till his parents, medical staff, and the public found out, he did NOT have Ebola.

"Where's the urgency here?," Eyewitness News asked U.S. Senator Charles Schumer of New York.

"Well, the sooner you can get a test result, the better, but there's another thing that has to be involved too. You need total accuracy," said Ririe.

Senator Schumer says city health officials concerned about accuracy and training have delayed the use of the one-hour Ebola tester. It's clear however that the FDA felt confident enough in the device's accuracy to give it EMERGENCY APPROVAL.

The military has been using it in West Africa since last August and dozens of hospital including Bellevue already have the device for rapid testing of the common flu and other virus:

"Has the city told you when or is there a timeline here to when they're going to be using this?," we asked.

"The city has told us they're very interested, they're going to try to move it as quickly as possible, and I've urged them to move it as quickly as possible but make sure accuracy has to be first," said Schumer.

"The benefits of a fast result for a disease like Ebola speaks for itself. Every hour left untreated is an opportunity wasted," he said.

The city's Health and Hospital Corporation says that "this new test is currently being evaluated by the State and City Health departments, along with CDC partners, to insure it would be an effective tool."

The statement goes on to say that the city's current testing process is reliable and accurate.

No word from the state health department on how it will take to approve the new Ebola test.

Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading

Top 5 Most Recently Viewed Articles

BioVaxys Unveils Private Placement to Boost Growth Initiatives

Updated Category News Views 83

BioVaxys Technology Corp. Announces Private Placement Offering BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) is thrilled to share its plans for a strategic move that aims to elevate its operational capabilities. The company intends to initiate a non-brokered private placement offering, introducing up to 14,285,715 units at a price of CAD$0.07 each. This initiative is...

Continue Reading
Cardiff Oncology Secures $40 Million Through Oversubscribed Offering

Updated Category News Views 104

Cardiff Oncology Completes Significant Stock Offering Cardiff Oncology, Inc. (Nasdaq: CRDF) has recently made headlines with its successful pricing of an underwritten offering, targeting a remarkable $40 million. This offering consists of 15,384,619 shares of its common stock, priced at $2.60 per share, with all shares being offered by the Company itself. The...

Continue Reading
Sungrow and Globeleq Partner for Major Battery Storage Project

Updated Category News Views 301

Sungrow and Globeleq Join Forces on Groundbreaking Energy Project Sungrow, a prominent name in the renewable energy sector, and Globeleq, a trusted independent power producer, have made a significant commitment by signing a term sheet. This partnership focuses on the supply and long-term service for the ambitious 153MW / 612MWh Red Sands Battery Energy Storage System...

Continue Reading
Helios Technologies Unveils the Advanced S35 Display System

Updated Category News Views 442

Helios Technologies Launches the Versatile S35 Display Helios Technologies, Inc. (NYSE: HLIO), known for its expertise in highly engineered motion control and electronic controls technology, has recently introduced the S35 display. This new addition showcases a unique blend of advanced technology, rugged durability, and user-friendliness, making it an exceptional...

Continue Reading
Ameriprise Financial Soars to New Heights: Stock Insights

Updated Category News Views 47

Ameriprise Financial Achieves All-Time High Ameriprise Financial Inc (NYSE: AMP) has recently marked an extraordinary achievement with its stock price reaching an all-time high of $524.01. This significant increase not only highlights the company’s performance but also reflects a robust surge in investor confidence, demonstrated by a remarkable 65.08% increase over the...

Continue Reading